Clinical Trial Update: Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

View source ↗

Summary

This clinical trial update describes biomarkers studied in people at risk for myelodysplastic syndromes and in healthy participants, sponsored by Oxford Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Leukemia, Myelodysplastic Syndromes | Status: UNKNOWN